Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
foretinib
MET111647
NCT00742131
Solid Tumours
Phase 1
 
July 2015

Powered by ideaPoint, Inc.